Status:

RECRUITING

Performances on Cognitive Functions and Brain Function and Follow-up After Different Treatments in Patients With Autonomous Cortisol Secretion: a Single-center, Prospective, Observational Study

Lead Sponsor:

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Conditions:

Autonomous Cortisol Secretion

Adrenal Incidentaloma

Eligibility:

All Genders

20-65 years

Brief Summary

This is a single center, prospective, observational study to explore and evaluate the differences on cognitive function and brain function by functional-MRI in autonomous cortisol secretion patients, ...

Detailed Description

Glucocorticoids, mainly cortisol, play a crucial role in the allostatic process of adjustment to stressors and can determine important changes in central nervous system structures. It is well known th...

Eligibility Criteria

Inclusion

  • age 20-65 years;
  • ≥ 6 years of education;
  • right-handed;
  • complete entire cognitive function tests;
  • adrenal lesions ≥ 1 cm in diameter;
  • patients with non-functioning adrenal adenomas;
  • patients with autonomous cortisol secretion.

Exclusion

  • \< 6 years of education;
  • age \< 20 years or \> 65 years;
  • maximum diameter of AI \<1cm;
  • active malignancies;
  • with a history of thyroid disease;
  • with a history of acute infection in the last month;
  • central nervous system diseases, including brain trauma, intracranial hemorrhage, acute cerebral infarction, etc;
  • contraindications of MRI examination: such as implantation of metal prosthesis in vivo, claustrophobia, etc;
  • adrenal tuberculosis;
  • suspected or diagnosed adrenocortical carcinoma;
  • unable to complete entire cognitive function tests;
  • current use of steroids or any drugs known to alter steroid synthesis or metabolism in the previous 3 months;
  • clinical Cushing syndrome;
  • Cushing disease;
  • primary hyperaldosteronism;
  • pheochromocytoma;
  • severe impairment of heart, liver, kidney and other organs;
  • pregnant and lactating women

Key Trial Info

Start Date :

October 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 1 2026

Estimated Enrollment :

62 Patients enrolled

Trial Details

Trial ID

NCT05357456

Start Date

October 1 2021

End Date

October 1 2026

Last Update

May 2 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Endocrinology, Drum Tower Hospital affiliated to Nanjing University Medical School

Nanjing, Jiangsu, China, 210008